Researchers at the Icahn School of Medicine at Mount Sinai have identified a new approach to controlling bacterial infections.
EU reshapes HTAs: is the industry ready for it? – Pharmaceutical Technology
On 12 January, the EMA implemented the revamped EU HTA regulation for the assessment of cancer therapies and cell and gene therapies. Credit: Vepar5 via